ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIgnacio Martín‐Loeches, Richard G. Wunderink, Antoni Torres et al.|Intensive Care Medicine|2023Cited by 289
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIgnacio Martín‐Loeches, Richard G. Wunderink, Antoní Torres et al.|European Respiratory Journal|2023Cited by 139
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry PatientsTimothy R. Aksamit, Beth Shoshanna Zha, David Fraulino et al.|American Journal of Respiratory and Critical Care Medicine|2024Cited by 36
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumoniaForest W. Arnold, Jordi Rello, Gustavo Lopardo et al.|Respiratory Medicine|2018Cited by 23
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop ReportSara C. Auld, Scott E. Evans, Ajay Sheshadri et al.|Annals of the American Thoracic Society|2024Cited by 22